Cryoport, Inc
(NASDAQ:CYRX)

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which in...

Website: http://www.cryoport.com

Founded: 1990

Full Time Employees: 105

Sector: Industrials

Industry: Integrated Freight & Logistics

Consumer Cyclical Logistics

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-06-27

life sciences services revenue	26,898,000	25,005,000	24,258,000	24,369,000	22,865,000	39,556,000	39,278,000	38,040,000	36,786,000
life sciences products revenue	20,900,000	20,445,000	19,975,000	21,085,000	18,175,000	19,976,000	17,386,000	19,557,000	17,806,000
total revenue	47,798,000	45,450,000	44,233,000	45,454,000	41,040,000	59,532,000	56,664,000	57,597,000	54,592,000
yoy	16.47%	-23.65%	-21.94%	-21.08%	-24.82%
qoq	5.17%	2.75%	-2.69%	10.76%	-31.06%	5.06%	-1.62%	5.50%
cost of services revenue	13,747,000	12,859,000	12,201,000	12,449,000	11,920,000	21,279,000	21,220,000	21,105,000	21,602,000
cost of products revenue	12,138,000	10,880,000	10,707,000	11,628,000	10,479,000	10,972,000	10,059,000	11,302,000	11,215,000
total cost of revenue	25,885,000	23,739,000	22,908,000	24,077,000	22,399,000	32,251,000	31,279,000	32,407,000	32,817,000
gross margin	21,913,000	21,711,000	21,325,000	21,377,000	18,641,000	27,281,000	25,385,000	25,190,000	21,775,000	23,261,000	24,266,000	24,733,000	27,072,000	26,277,000	26,417,000	28,838,000	22,341,000	23,113,000	23,513,000	25,402,000	24,550,000	19,893,787	6,055,253	5,126,996	5,257,964	4,932,309	4,627,057	4,338,389	3,453,901	2,816,188	2,736,007	2,503,707	2,184,363	1,713,250	1,606,497	1,393,189	1,253,497	796,835	781,950	581,807	384,282	436,313	487,912	370,079	234,537	224,958	339,355	143,150	167,061	72,102	54,642
yoy	17.55%	-20.42%	-15.99%	-15.14%	-14.39%	17.28%	4.61%	1.85%	-19.57%	-11.48%	-8.14%	-14.23%	21.18%	13.69%	12.35%	13.53%	-9.00%	16.18%	288.31%	395.46%	366.91%	303.34%	30.87%	18.18%	52.23%	75.14%	69.12%	73.28%	58.12%	64.38%	70.31%	79.71%	74.26%	115.01%	105.45%	139.46%	226.19%	82.63%	60.26%	57.21%	63.85%	93.95%	43.78%	158.53%	40.39%	212.00%	521.05%
qoq	0.93%	1.81%	-0.24%	14.68%	-31.67%	7.47%	0.77%	15.68%	-6.39%	-4.14%	-1.89%	-8.64%	3.03%	-0.53%	-8.40%	29.08%	-3.34%	-1.70%	-7.44%	3.47%	23.41%	228.54%	18.11%	-2.49%	6.60%	6.60%	6.65%	25.61%	22.64%	2.93%	9.28%	14.62%	27.50%	6.65%	15.31%	11.14%	57.31%	1.90%	34.40%	51.40%	-11.93%	-10.58%	31.84%	57.79%	4.26%	-33.71%	137.06%	-14.31%	131.70%	31.95%
gross margin %	45.85%	47.77%	48.21%	47.03%	45.42%	45.83%	44.80%	43.73%	39.89%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
operating costs and expenses:
selling, general and administrative	27,620,000	27,276,000	26,734,000	26,908,000	24,191,000	37,057,000	37,654,000	35,963,000	38,304,000	38,814,000	36,023,000	38,802,000	33,241,000	32,635,000	30,235,000	30,563,000	26,622,000	27,586,000	23,901,000	24,688,000	21,388,000																			1,754,875	2,835,372	2,157,771	2,026,357	1,978,091	1,492,732	1,510,708	1,427,850	1,338,170	1,305,562	1,240,413	1,222,074	-3,998,132	1,392,937	1,341,333	1,269,272	1,172,904	1,740,324	1,564,456	1,628,322	1,182,124	1,080,768	1,114,304	943,265
engineering and development	3,907,000	4,466,000	4,523,000	4,118,000	3,934,000	4,155,000	4,157,000	4,646,000	4,752,000	4,749,000	5,152,000	4,263,000	3,876,000	4,677,000	3,985,000	3,522,000	3,538,000	3,890,000	4,188,000	4,462,000	4,304,000	3,493,113	2,311,718	1,946,443	1,732,726	1,069,585	1,640,528	540,933	489,596	598,761	463,361	448,591	329,730	380,315	344,798	230,736	249,843
total operating costs and expenses	31,527,000	31,742,000	31,257,000	31,026,000	28,125,000	41,212,000	41,811,000	104,418,000	43,056,000	93,132,000	41,175,000	43,065,000	37,117,000	37,312,000	34,220,000	34,085,000	30,160,000	31,476,000	28,089,000	29,150,000	25,692,000	29,739,678	16,787,690	10,972,437	8,844,195	5,810,660	16,978,807	6,642,787	5,594,447	5,036,053	4,897,267	4,968,892	3,982,668	3,984,425	3,594,617	3,257,083	3,022,810	2,957,667	2,761,205	3,205,925	3,063,137	2,258,067	2,104,081	2,063,096	1,591,784	1,599,987	1,507,094
income from operations	-9,614,000	-10,031,000	-9,932,000	-9,649,000	-9,484,000	-13,931,000	-16,426,000	-79,228,000	-21,281,000	-69,871,000	-16,909,000	-18,332,000	-10,045,000	-11,035,000	-7,803,000	-5,247,000	-7,819,000	-8,363,000	-4,576,000	-3,748,000	-1,142,000	-9,845,891	-10,732,437	-5,845,441	-3,586,231			-2,304,398	-2,140,546	-2,219,865	-2,161,260	-2,465,185	-1,798,305	-2,271,175	-1,988,120	-1,863,894	-1,769,313	-2,160,832	-1,979,255	-2,624,118	-2,678,855	-1,821,754	-1,616,169	-1,693,017	-1,357,247	-1,375,029	-1,167,739	-1,274,562	-1,256,991	-1,286,747	-1,260,075	4,637,055	-1,549,003	-1,553,832	-1,540,543	-1,471,125	-2,061,474	-1,941,998	-1,960,081	-1,463,245	-1,342,742	-1,482,626	-1,308,461	2,879,539	-891,180	-1,041,048	-951,508	-684,835	-720,958	-1,014,115	-775,785
yoy	1.37%	-28.00%	-39.53%	-87.82%	-55.43%	-80.06%	-2.86%	332.18%	111.86%	533.18%	116.70%	249.38%	28.47%	31.95%	70.52%	39.99%	584.68%	-15.06%	-57.36%	-35.88%	-68.16%			153.66%	67.54%			-6.52%	19.03%	-2.26%	8.71%	32.26%	1.64%	5.11%	0.45%	-28.97%	-33.95%	18.61%	22.47%	55.00%	97.37%	32.49%	38.40%	32.83%	7.98%	6.86%	-7.33%	-127.49%	-18.85%	-17.19%	-18.21%	-415.20%	-24.86%	-19.99%	-21.40%	0.54%	53.53%	30.98%	49.80%	-150.82%	50.67%	42.42%	37.51%	-520.47%	23.61%	2.66%	22.65%
qoq	-4.16%	1.00%	2.93%	1.74%	-31.92%	-15.19%	-79.27%	272.29%	-69.54%	313.22%	-7.76%	82.50%	-8.97%	41.42%	48.71%	-32.89%	-6.50%	82.76%	22.09%	228.20%	-88.40%	-8.26%	83.60%	63.00%				7.65%	-3.57%	2.71%	-12.33%	37.08%	-20.82%	14.24%	6.66%	5.35%	-18.12%	9.17%	-24.57%	-2.04%	47.05%	12.72%	-4.54%	24.74%	-1.29%	17.75%	-8.38%	1.40%	-2.31%	2.12%	-127.17%	-399.36%	-0.31%	0.86%	4.72%	-28.64%	6.15%	-0.92%	33.95%	8.97%	-9.43%	13.31%	-145.44%	-423.12%	-14.40%	9.41%	38.94%	-5.01%	-28.91%	30.72%
operating margin %	-20.11%	-22.07%	-22.45%	-21.23%	-23.11%	-23.40%	-28.99%	-137.56%	-38.98%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	NaN%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%
other income:
investment income	3,090,000	3,357,000	3,402,000	1,466,000	1,573,000	1,427,000	3,059,000	2,809,000	2,600,000	2,615,000	2,848,000	2,647,000	2,467,000	2,677,000	2,485,000	2,048,000	1,264,000	1,635,000	851,000	368,000	398,000
interest expense	-432,000	-634,000	-526,000	-618,000	-583,000	-636,000	-889,000	-1,245,000	-1,338,000	-1,306,000	-1,357,000	-1,331,000	-1,509,000	-1,456,000	-1,609,000	-1,586,000	-1,491,000	-1,126,000	-1,189,000	-1,164,000	-1,210,000	-1,077,751	-1,081,542	-398,256	-2,451			-333,910	-338,728							-26	-15,667	-19,305	-21,242	-81,194	-79,946	-601,002	-303,800	-242,678	-48,605	-7,854	-1,128,878	-157,673	-31,786	-512,776	-82,219	48,183	-11,896	-11,759	-24,599	-207,711	-78,974	-107,757	-133,311	-171,177	-151,428	-157,452	-138,708	5,305,564	-1,169,337	-1,610,059	-1,820,198	-740,168	-739,347	-658,099	-555,769
other expense	-2,368,000															-4,028,000	-5,017,000				-535,000																	-1,453	-1,915	-4,872	-1,347	-2,707		-1,437	-1,906	-1,876
total other income	290,000	2,636,000	3,401,000	-2,091,000	690,000	-4,717,000	17,880,000	1,622,000	2,601,000	6,123,000	4,111,000	612,000	4,963,000																																					-13,672,901				2,730						-39,958	-113,894		-18,743				1,314,784
loss from continuing operations before provision for income taxes	-9,324,000			-11,740,000	-8,794,000
provision for income taxes	-108,000	-1,126,000	-165,000	-274,000	-234,000	-29,000	-649,000	-383,000	-215,000	1,359,000	-471,000	-635,000	-492,000	-190,500	-57,000	-364,000	-341,000			-499,000	-1,038,000			-49,833				-9,624		-4,214	-2,102	-12,825	-813	-912			-4,231	-2,878	-2,484		-305		-3,320				-1,600
loss from continuing operations	-9,432,000			-12,014,000	-9,028,000
loss from discontinued operations	-1,112,000				-2,953,000
net income	-10,544,000	-11,644,000	-6,943,000	105,180,000	-11,981,000	-18,677,000	805,000	-77,989,000	-18,895,000	-62,389,000	-13,269,000	-18,355,000	-5,574,000	-9,436,000	-5,316,000	-9,177,000	-13,404,000	-260,086,000	-6,526,000	-5,389,000	-3,527,000	-11,529,540	-11,417,821	-5,802,746	-3,942,893			-2,528,491	-2,386,902	-2,258,264	-2,143,687	-2,470,890	-2,682,760	-2,269,669	-1,979,664	-1,860,457	-1,789,211	-2,184,468	-3,934,714	-2,710,184	-2,760,453	-2,425,463	-1,924,264	-1,937,132	-1,407,758	-1,384,759	-2,297,264	-1,441,910	-1,840,331	-14,959,648	-1,323,537	4,659,140	-1,567,011	-1,552,702	-1,545,807	-1,669,399	-2,079,565	-2,030,110	-2,053,854	-1,857,017	-1,456,636	-1,509,821	-1,328,804	5,079,724	2,450,669	-7,186,322	363,276	-5,459,296	-1,454,081	-1,569,293	-8,222,481
yoy	-11.99%	-37.66%	-962.48%	-234.87%	-36.59%	-70.06%	-106.07%	324.89%	238.98%	561.18%	149.60%	100.01%	-58.42%	-96.37%	-18.54%	70.29%	280.04%	2155.82%	-42.84%	-7.13%	-10.55%			129.49%	65.19%			2.33%	-11.03%	-0.50%	8.29%	32.81%	49.94%	3.90%	-49.69%	-31.35%	-35.18%	-9.94%	104.48%	39.91%	96.09%	75.15%	-16.24%	34.34%	-23.51%	-90.74%	73.57%	-130.95%	17.44%	863.46%	-14.38%	-379.09%	-24.65%	-23.52%	-24.74%	-10.10%	42.76%	34.46%	54.56%	-136.56%	-159.44%	-78.99%	-465.78%	-193.05%	-268.54%	357.93%	-104.42%
qoq	-9.45%	67.71%	-106.60%	-977.89%	-35.85%	-2420.12%	-101.03%	312.75%	-69.71%	370.19%	-27.71%	229.30%	-40.93%	77.50%	-42.07%	-31.54%	-94.85%	3885.38%	21.10%	52.79%	-69.41%	0.98%	96.77%	47.17%				5.93%	5.70%	5.34%	-13.24%	-7.90%	18.20%	14.65%	6.41%	3.98%	-18.09%	-44.48%	45.18%	-1.82%	13.81%	26.05%	-0.66%	37.60%	1.66%	-39.72%	59.32%	-21.65%	-87.70%	1030.28%	-128.41%	-397.33%	0.92%	0.45%	-7.40%	-19.72%	2.44%	-1.16%	10.60%	27.49%	-3.52%	13.62%	-126.16%	107.28%	-134.10%	-2078.20%	-106.65%	275.45%	-7.34%	-80.91%
net income margin %	-22.06%	-25.62%	-15.70%	231.40%	-29.19%	-31.37%	1.42%	-135.40%	-34.61%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	NaN%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%
paid-in-kind dividend on series c convertible preferred stock	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000	-2,000,000		-2,000,000	-2,000,000	-2,000,000		-2,000,000	-2,000,000	-2,000,000	-2,196,000
net loss attributable to common stockholders	-12,544,000				-13,981,000	-20,677,000	-1,195,000	-79,989,000	-20,895,000	-64,389,000	-15,269,000	-20,355,000	-7,574,000	-11,436,000	-7,316,000	-11,177,000	-15,404,000	-262,086,000	-8,526,000	-7,389,000	-5,723,000													-2,269,669	-1,979,664	-1,860,457	-1,789,211	-2,184,468	-3,934,714	-2,785,644	-2,999,842	-2,664,851	-6,607,102	-3,950,128	-1,995,972	-3,183,660	-3,066,773
net income per share	-0.23	-0.21	-0.17	2.33	-0.28	-0.42	-0.02	-1.62	-0.43	-1.32	-0.31	-0.42	-0.16	-0.24	-0.15	-0.23	-0.31	-5.7	-0.18	-0.16	-0.13	-1.39	-0.29	-0.15	-0.11			-0.08	-0.08	-0.08	-0.07	-0.09	-0.1	-0.09	-0.08	-0.08	-0.1	-0.14	-0.28	-0.09	-0.42	-0.41	-1.31	-2.3	-0.03	-0.05
weighted-average common shares issued and outstanding — basic and diluted	49,897,817	50,071,665	50,125,268	50,257,112
impairment loss								63,809,000
gain on extinguishment of debt							17,326,000	1,179,000		1,419,750	5,679,000
other income		-87,000	525,000	-2,939,000	-300,000	-5,508,000	-1,616,000	-1,121,000	1,339,000	4,814,000	-3,059,000	-704,000	4,005,000	1,855,000	1,668,000			-1,354,000	-588,000	-346,000		-1,465,691	367,093	490,784	-321,186	427,653	133,499	119,441	91,472	35,068	19,675	7,120	15,768	2,418	8,456	3,463							-975				953
income from continuing operations before provision for income taxes		-6,193,750	-6,531,000
income from continuing operations		-6,362,000	-6,696,000
income from discontinued operations		-3,123,000	-247,000	117,194,000
net income attributable to common stockholders		-13,644,000	-8,943,000	103,180,000
loss from continuing operations — basic and diluted				-280
loss per share from continuing operations - basic and diluted					-0.22
loss per share from discontinued operations - basic and diluted					-0.06
weighted-average common shares issued and outstanding - basic and diluted					49,947,012
income before provision for income taxes						-18,648,000	1,454,000	-77,606,000	-18,680,000	-63,748,000	-12,798,000	-17,720,000	-5,082,000	-7,959,000	-5,259,000	-8,813,000	-13,063,000	-260,962,000	-5,502,000	-4,890,000	-2,489,000	-11,628,333	-11,446,886	-5,752,913	-3,909,868			-2,518,867		-2,254,050	-2,141,585	-2,458,065	-2,681,947	-2,268,757	-1,979,664	-1,860,457	-1,784,980	-2,181,590	-3,932,230	-2,710,184	-2,760,148	-2,425,463	-1,920,944	-1,937,132	-1,407,758	-1,384,759	-2,295,664
weighted-average shares outstanding – basic and diluted						49,349,624	49,417,757	49,345,644	49,019,964	48,737,377	48,904,102	48,709,384			48,520,696	48,792,559			46,137,147				39,144,916	38,281,087	37,548,549		35,674,162	31,176,166	30,441,996		28,769,867	27,808,873	26,774,179		24,632,169	23,965,825	17,604,283	15,120,479	14,199,742		7,225,006	6,505,016	5,055,649	5,006,219	60,057,846	60,048,933	59,989,321	48,850,513

service revenues										37,025,000	36,022,000	35,204,000	35,836,000	33,088,000	33,296,000	34,585,000	32,910,000	31,723,000	30,899,000	29,679,000	26,765,000
product revenues										20,235,000	20,135,000	21,817,000	26,981,000	27,270,000	27,168,000	29,568,000	19,392,000	24,717,000	25,794,000	26,512,000	26,519,000
total revenues										57,260,000	56,157,000	57,021,000	62,817,000	60,358,000	60,464,000	64,153,000	52,302,000	56,440,000	56,693,000	56,191,000	53,284,000
cost of service revenues										21,933,000	20,803,000	20,008,000	19,076,000	18,445,000	18,913,000	19,111,000	18,718,000	18,888,000	18,114,000	16,742,000	15,552,000
cost of product revenues										12,066,000	11,088,000	12,280,000	16,669,000	15,636,000	15,134,000	16,204,000	11,243,000	14,439,000	15,066,000	14,047,000	13,182,000
total cost of revenues										33,999,000	31,891,000	32,288,000	35,745,000	34,081,000	34,047,000	35,315,000	29,961,000	33,327,000	33,180,000	30,789,000	28,734,000
paid in kind dividend on series c convertible preferred stock													-2,000,000				-2,000,000
weighted-average common shares outstanding – basic and diluted													48,362,501	48,987,295			49,660,579	45,927,591		45,757,532	43,804,483	38,582,432				33,394,285				28,210,648				22,963,382						7,339,855
total other expense														3,076,000	2,544,000	-3,566,000	-5,244,000	-252,599,000	-926,000	-1,142,000	-1,347,000																											-3,579,925.75	-583,340		-63,462	-5,135.75	-18,008		-5,264	-198,274	-18,091	-88,112	-92,173			-27,195		-550,010	3,341,849	-6,143,674		-4,773,661	-733,123	-555,178	-7,445,896
benefit from income taxes																		876,000	-1,024,000
revenues																						7,583,791.25	11,172,084	9,389,006	9,774,075	9,242,066	9,583,334	8,463,588	6,652,912	5,690,898	5,285,355	4,627,011	4,023,189	3,322,000	3,002,655	2,917,378	2,712,234	1,976,826	1,917,566	1,555,545	1,458,563	1,437,028	1,431,063	1,198,544	975,188	825,000	936,588													100,066	99,569	124,409	151,460	-42,770	20,707	8,478
cost of revenues																						3,473,738	5,116,831	4,262,010	4,516,111	4,309,757	4,956,277	4,125,199	3,199,011	2,874,710	2,549,348	2,123,304	1,838,826	1,608,750	1,396,158	1,524,189	1,458,737	1,179,991	1,135,616	973,738	1,074,281	1,000,715	943,151	828,465	740,651	600,042	597,233	691,676	590,266	507,725	433,321	-1,065,265	368,795	344,440	353,618	329,928	344,702	363,550	354,280	273,713	256,523	378,217	394,535	-458,144	132,418	177,267
general and administrative																						5,139,325.25	10,794,110	5,733,149	4,030,042	2,132,865	9,376,686	3,258,781	2,696,859	2,447,962	2,613,476	2,668,845	2,068,510	2,031,446	1,896,845	1,789,514	1,703,032	1,507,634	1,429,768
sales and marketing																						2,514,033.5	3,681,862	3,292,845	3,081,427	2,608,210	5,961,593	2,843,073	2,407,992	1,989,330	1,820,430	1,851,456	1,584,428	1,572,664	1,352,974	1,236,833	1,069,935	1,235,353	1,195,638
benefit for income taxes																						-13,448.25	29,065		-33,025				900
warrant inducement and repricing expense																																	-899,410
loss before benefit for income taxes																													-2,387,802
warrant repricing expense																																							-1,929,818
undeclared cumulative preferred dividends																																								-75,460	-239,389	-239,388	-208,490	-110,427	-95,304	-71,874	-27,723
other expense:
research and development																																						214,680	135,799	144,478	227,765	100,296	77,724	85,005	99,052	89,279	79,244	79,542	118,490	118,436	92,643	-304,606	94,424	101,656	108,952	145,212	120,702	124,705	101,230	107,474	105,020	114,514	122,121
preferred stock beneficial conversion charge																																											-4,474,348	-1,902,569	-492,910	-1,727,027	-741,786
debt conversion expense																																																	-552,750	-13,161,017
change in fair value of derivatives
net loss attributable to common stockholders – basic and diluted																																															-0.05
net revenues																																																456,279.25	757,327	579,827	487,963	183,012.25	307,153	233,597	191,299	94,679.5	144,254	110,713	123,751
operating expenses:
total operating expenses																																																1,024,404.5	1,424,052	1,358,849	1,314,717	-4,302,738	1,487,361	1,442,989	1,378,224	1,318,116	1,861,026	1,689,161	1,729,552	1,289,598	1,185,788			-2,464,165	779,469	872,259	816,034	564,728	563,962	885,144	670,831
change in fair value of derivative liabilities																																																5,211.25	1,196	892	18,757	-27,696	-6,112	14,489	19,335	10,010	60,185	14,685	34,283	-227,270	33,987	126,345	116,528	-3,101,225	4,508,352	-4,535,848	3,134,298
income before income taxes																																																-4,530,879	-1,840,331	-14,959,648	-1,323,537	-1,165,980.5	-1,567,011	-1,551,102	-1,545,807	-1,540,482.25	-2,079,565	-2,030,110	-2,052,254	-1,857,017	-1,456,636	-1,509,821	-1,327,204			-7,184,722	363,276	-5,458,496	-1,454,081	-1,569,293	-8,221,681
income taxes																																																				-1,598		1,600		400			1,600				1,600	-1,598		1,600		800			800
net loss per common share, basic and diluted																																																-0.1	-0.03	-0.38	-0.03	-0.05	-0.04	-0.04	-0.04	-0.05	-0.07	-0.07	-0.07			-0.15	-0.16
basic and diluted weighted-average common shares outstanding																																																	58,995,821	39,110,774	38,062,826		37,760,628	37,760,628	37,760,628	28,974,843	28,246,661	27,967,380	27,690,408	13,301,769		10,268,637	8,146,477					41,238,185	41,208,555	41,167,472	41,018,074
gross loss																																																				334,317	-61,642	-110,843	-162,319	-153,009	-200,448	-252,837	-230,529	-173,647	-156,954	-253,808	-243,075	415,374	-111,711	-168,789	-135,474	-120,107	-156,996	-128,971	-104,954
interest income																																																								-573	698	4,960	6,855	4,675	3,547	3,912	3,437	-6,540	2,834	2,233	1,481	1,866	6,224	11,194	12,814
loss on sale of property and equipment
net income per common share:
basic																																																												-0.1	-0.11			-0.275	0.5		0.01
diluted																																																												-0.1	-0.11			-0.275	0.26		0.01
weighted-average common shares outstanding:
basic																																																													13,564,985						42,939,649
diluted																																																													13,564,985						46,563,395
costs and expenses:
total costs and expenses																																																														1,228,818	1,065,386
selling, general and administrative expenses																																																																549,386.25	690,043	779,193	728,309	496,886	550,670	779,691	560,040
research and development expenses																																																																67,554.25	89,426	93,066	87,725	67,842	13,292	105,453	110,791
loss on sale of fixed assets																																																																788			-797
loss on extinguishment of debt																																																																				-4,035,359			-6,902,941
income (loss) before income taxes																																																																-1,270,944	2,450,669
weighted average common shares outstanding:
basic																																																																	4,911,756
diluted																																																																	6,577,322
gain (loss) on extinguishment of debt																																																																						91,727
net loss per common share:
basic and diluted																																																																		-0.16
weighted average common shares outstanding:
basic and diluted																																																																		46,154,705
net sales																																																																			13,703	6,511	9,207	5,982	13,424
cost of sales																																																																			149,177	126,618	166,203	134,953	118,378
net loss available to common stockholders per common share:
basic and diluted loss per common share																																																																				-0.14	-0.04	-0.04	-0.2

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-06-27	2008-03-31

assets
current assets:
cash and cash equivalents	272,912,000	250,494,000	255,811,000	243,416,000	36,102,000	45,289,000	44,665,000	46,458,000	49,663,000	46,346,000	59,473,000	67,314,000	38,538,000	36,595,000	30,724,000	37,034,000	134,448,000	139,101,000	43,680,000	60,357,000	85,494,000	36,873,000	161,987,083	44,326,038	50,622,454	47,234,770	44,585,154	80,642,213	32,771,986	37,327,125	13,849,644	20,011,137	18,993,994	15,042,189	15,397,512	12,854,526	14,532,860	2,558,028	4,525,720	2,792,526	5,247,425	7,059,709	2,385,919	1,405,186	773,922	103,343	170,505	369,581	219,970	532,469	585,107	1,669,634	2,971,567	4,617,535	2,796,089	4,953,454	7,056,604	9,278,443	2,710,976	3,745,745	2,097,202	3,629,886	647,308	1,120,758	556,922	249,758	776,166	1,219,046	2,189,698	2,231,031	2,231,031
short-term investments	130,722,000	160,714,000	165,503,000	182,559,000	207,929,000	216,460,000	228,001,000	380,684,000	398,881,000	410,409,000	406,389,000	437,360,000	484,076,000	486,728,000	498,801,000	513,584,000	465,063,000	489,698,000	305,802,000	289,056,000	267,721,000	56,444,000	40,952,522	163,891,831	46,809,959	47,060,786	48,917,336	14,103,653	14,500,748	9,930,968	9,884,918
accounts receivable	39,004,000	33,359,000	34,914,000	33,409,000	28,371,000	45,778,000	43,461,000	40,160,000	41,253,000	42,074,000	42,626,000	43,076,000	45,574,000	43,858,000	44,419,000	43,903,000	35,837,000	39,412,000	38,460,000	38,102,000	36,504,000	31,377,000	7,783,502	7,038,733	6,139,538	7,098,191	7,497,190	6,095,858	4,208,333	3,543,666	3,197,224	3,618,929	2,385,904	1,625,476	1,464,136	1,250,731	1,467,849	1,000,226	1,015,265	1,020,999	616,785	702,908	757,436	589,699	407,459	408,080	492,865	515,825	635,687	387,669	201,137	170,368	144,766	146,124	83,708	111,387	75,945	55,794	35,924	58,940	32,816	81,036	10,030	7,273	7,555	2,546	4,822	4,473	2,051	21,411	21,411
inventories	21,750,000	23,188,000	23,326,000	23,035,000	23,340,000	22,470,000	23,552,000	23,609,000	25,020,000	26,206,000	29,104,000	28,821,000	26,487,000	27,678,000	24,542,000	23,070,000	22,062,000	16,501,000	13,484,000	11,665,000	11,544,000	10,535,000	476,622	538,376	464,588	473,961	350,920	306,438	227,090	220,514	130,299	97,290	121,926	114,796	90,254	72,621	70,960	82,191	83,544	69,801	52,880	79,230	104,804	69,680	66,958	58,804	38,601	29,703	30,008	43,305	55,459	55,919	47,506	51,754	47,130	42,679	44,963	44,224	59,863	60,228					512,556	530,241	533,204	421,345	195,036	121,952	121,952
prepaid expenses and other current assets	6,147,000	8,419,000	5,289,000	7,071,000	7,444,000	11,574,000	10,658,000	11,075,000	10,887,000	10,077,000	11,548,000	8,616,000	9,959,000	9,317,000	10,639,000	8,250,000	8,363,000	8,804,000	8,958,000	12,574,000	18,485,000	11,928,000	1,444,303	891,652	1,002,189	1,096,855	872,436	526,648	741,614	752,269	882,141	502,617	541,462	516,427	264,343	308,929	321,419	606,823	288,955	248,729																							147,837	140,778	166,749	170,399	128,960	126,404	154,940	153,016	153,016
total current assets	470,535,000	476,174,000	484,843,000	489,490,000	411,276,000	341,571,000	350,337,000	501,986,000	525,704,000	535,112,000	549,140,000	585,187,000	604,634,000	604,176,000	609,125,000	625,841,000	665,773,000	693,516,000	410,384,000	411,754,000	419,748,000	147,157,000	212,644,032	216,686,630	105,038,728	102,964,563	102,223,036	101,674,810	52,449,771	51,774,542	27,944,226	24,229,973	22,043,286	17,298,888	17,216,245	14,486,807	16,393,088	4,247,268	5,913,484	4,132,055	6,206,055	8,030,520	3,511,386	2,161,902	1,370,752	655,539	783,392	1,111,614	988,383	1,004,128	898,733	1,934,551	3,201,424	5,132,751	3,061,571	5,358,839	7,656,734	9,997,675	3,111,090	4,328,242	2,322,747	3,905,340	895,205	1,370,924	1,345,432	1,053,997	1,543,629	1,979,464	2,747,645	2,731,080	2,731,080
property and equipment	89,805,000	85,448,000	83,233,000	81,565,000	80,481,000	88,839,000	88,281,000	86,653,000	86,008,000	84,858,000	74,520,000	69,008,000	71,259,000	63,603,000	57,680,000	54,011,000	50,734,000	49,029,000	42,853,000	37,811,000	31,694,000	30,036,000	15,178,619	13,702,732	12,459,703	11,833,057	11,378,987	10,338,007	5,124,655	4,357,498	3,578,494	3,038,618	2,572,298	2,511,174	2,083,467	2,311,680	2,129,397	1,373,207	1,410,349	1,319,741	875,673	767,123	381,362	307,926	349,515	393,372	364,728	408,892	464,122	516,628	524,075	562,873	659,051	682,021	736,447	677,962	658,887	669,580	679,487	696,238	734,996	559,241
operating lease right-of-use assets	39,299,000	39,720,000	40,224,000	38,206,000	39,102,000	47,188,000	30,113,000	29,684,000	31,029,000	32,653,000	32,561,000	30,011,000	30,270,000	26,877,000	24,820,000	22,740,000	17,948,000	20,675,000	18,425,000	17,936,000	15,996,000	14,044,000	8,113,923	5,868,513	6,068,616	4,460,319	4,612,788	4,160,747	1,711,727
intangible assets	138,721,000	138,082,000	141,254,000	143,590,000	145,414,000	170,464,000	175,815,000	178,388,000	190,088,000	194,382,000	192,962,000	194,992,000	188,175,000	191,009,000	192,140,000	196,013,000	197,608,000	201,427,000	205,240,000	209,127,000	209,267,000	213,908,000	4,891,124	4,984,012	5,073,182	5,177,578	5,286,690		157,708	137,220	124,822	117,818	105,996	90,646	56,533	29,728	15,199	6,323	4,860	8,581	13,484	118,257	127,327	136,821	146,315	156,407	167,425	180,086	189,094	216,817	294,550	321,698	350,895	379,083	406,320	386,774	356,470	354,854	346,232	346,555	335,894	311,965	244,244	259,616	268,230	264,364	278,519	1,107	1,107	474	474
goodwill	22,137,000	22,400,000	22,409,000	18,713,000	20,960,000	51,660,000	54,057,000	52,384,000	107,588,000	108,403,000	148,954,000	149,308,000	151,616,000	151,117,000	147,458,000	145,201,000	146,591,000	146,954,000	146,371,000	146,974,000	141,305,000	145,282,000	10,999,722	10,999,722	10,999,722	10,999,722	11,149,663	11,149,663
deposits	2,046,000	2,092,000	2,097,000	2,096,000	1,997,000	2,902,000	1,493,000	1,668,000	1,674,000	1,680,000	1,656,000	1,210,000	1,218,000	1,017,000	926,000	926,000	944,000	950,000	955,000	947,000	946,000	1,184,000	535,750	534,978	483,300	437,299	406,686	407,369	350,494	350,837	351,844	351,844	363,403	363,403	363,403	363,403	363,403	363,403	363,403	363,403	363,403
deferred tax assets	1,066,000	1,073,000	268,000	267,000	614,000	868,000	1,669,000	1,578,000	758,000	656,000	863,000	934,000	937,000	947,000	1,642,000
total assets	763,609,000	764,989,000	774,328,000	773,927,000	699,844,000	703,492,000	701,765,000	852,341,000	942,849,000	957,744,000	1,000,656,000	1,030,650,000	1,048,109,000	1,038,746,000	1,033,791,000	1,046,329,000	1,081,332,000	1,112,970,000	824,386,000	825,308,000	819,708,000	552,405,000	252,363,170	252,776,587	140,123,251	135,872,538	135,057,850	133,146,095	59,794,355	56,620,097	31,999,386	27,738,253	25,084,983	20,264,111	19,719,648	17,191,618	18,901,087	5,990,201	7,692,096	5,823,780	7,458,615	8,915,900	4,020,075	2,606,649	1,866,582	1,205,318	1,324,903	1,709,950	1,650,957	1,757,317	1,737,102	2,838,866	4,231,114	6,213,599	4,224,082	6,432,933	8,681,449	11,031,467	4,136,809	5,371,035	3,403,637	4,776,546
liabilities and stockholders’ equity
current liabilities:
accounts payable and other accrued expenses	15,937,000	15,283,000	13,884,000	14,756,000	13,442,000	27,208,000	25,194,000	24,805,000	27,376,000	26,995,000	27,875,000	26,124,000	25,860,000	28,046,000	27,441,000	31,086,000	28,309,000	28,583,000	29,235,000	29,336,000	27,083,000	24,844,000	9,663,211	6,509,745	3,171,821	2,498,375	3,130,663	3,416,805	2,326,143	1,709,397	1,885,003	2,210,955	1,345,047	1,259,629	1,141,821	1,369,223	1,656,708	1,184,330	1,366,543	1,271,926	1,109,243	856,000	562,340	758,696	713,465	703,084	538,988	579,678
accrued compensation and related expenses	17,007,000	12,980,000	10,864,000	9,400,000	12,681,000	13,093,000	11,275,000	10,690,000	14,062,000	11,409,000	10,426,000	8,717,000	10,450,000	8,458,000	8,625,000	8,354,000	12,096,000	9,912,000	8,649,000	6,781,000	8,233,000	7,441,000	2,554,753	1,852,186	2,671,473	1,903,720	1,567,365	1,534,468	1,753,499	1,262,478	884,893	902,919	1,074,532	925,514	628,793	598,325	413,621	368,235	376,844	508,754	377,113	384,643	440,252	725,712	617,636	549,659	502,015	454,288	391,438	342,427	168,465	144,788	128,211	235,996	553,192	409,694	531,413	402,746	253,017	234,570	321,295	312,002
deferred revenue	2,314,000	943,000	1,447,000	1,677,000	1,774,000	1,106,000	1,091,000	1,317,000	1,777,000	1,308,000	1,580,000	927,000	1,009,000	439,000	549,000	818,000	517,000	547,000	308,000	459,000	495,000	445,000	236,975	330,272	341,150	367,867	423,537	221,776	37,918	66,315	15,387	19,106	23,073
current portion of operating lease liabilities	3,641,000	4,133,000	4,126,000	3,889,000	3,661,000	5,419,000	5,834,000	5,299,000	5,356,000	5,371,000	4,759,000	4,234,000	4,089,000	3,720,000	3,007,000												562,866	534,586	390,790
current portion of finance lease liabilities	419,000	422,000	428,000	427,000	340,000	488,000	470,000	365,000	301,000	286,000	195,000	191,000	114,000	128,000	96,000												24,252	25,940	23,531
current portion of convertible senior notes, net of discount of 0.8 million and 1.1 million, respectively	185,390,000
current portion of notes payable	159,000	163,000			149,000	143,000	153,000	110,000	110,000	149,000	70,000	61,000	61,000	60,000	1,010,000	1,079,000
total current liabilities	224,867,000	219,018,000	30,749,000	30,149,000	74,030,000	64,563,000	61,439,000	59,885,000	48,982,000	45,610,000	44,905,000	40,254,000	41,583,000	40,851,000	40,728,000	44,046,000	44,441,000	42,645,000	41,073,000	38,154,000	37,873,000	35,020,000	13,185,484	9,441,535	7,070,225	5,460,480	5,708,683	5,733,575	4,531,881	3,061,381	2,785,283	3,132,980	2,442,652	2,185,143	1,770,614	1,967,548	2,634,171	2,292,242	2,606,944	2,173,578	2,468,348	2,197,200	1,972,702	2,996,496	2,984,215	2,578,931	2,383,337	4,014,445	1,773,814	1,042,583	952,178	713,087	596,023	1,108,631	2,215,215	2,529,563	3,183,532	3,237,920	2,652,471	2,334,398	1,728,839	1,910,406	20,092,678	24,273,020	16,901,954	4,747,012	3,524,882	3,401,748	2,968,208	1,749,871	1,749,871
notes payable, net of current portion	1,027,000	1,087,000	1,291,000	1,328,000	1,122,000	1,114,000
operating lease liabilities, net of current portion	39,173,000	39,078,000	39,376,000	37,441,000	38,101,000	44,077,000	26,466,000	26,523,000	27,798,000	29,355,000	29,757,000	27,520,000	27,841,000	24,721,000	23,112,000	21,106,000	15,494,000	18,144,000	16,355,000	17,081,000	14,502,000	12,261,000	7,814,874	5,497,430	5,568,845	4,101,236	4,266,589	3,920,739	1,621,183
finance lease liabilities, net of current portion	680,000	741,000	840,000	934,000	758,000	1,245,000	1,306,000	1,137,000	916,000	954,000	632,000	624,000	202,000	216,000	171,000			51,000	64,000	83,000	92,000	112,000	123,654	146,570	149,297	8,539	14,834	18,981	27,138
deferred tax liabilities	1,580,000	1,354,000	664,000	985,000	878,000	2,531,000	3,526,000	2,651,000	2,414,000	2,816,000	4,708,000	4,658,000	5,110,000
other long-term liabilities	663,000	444,000	2,708,000	2,567,000	1,353,000	394,000	569,000	427,000	312,000	601,000	484,000	361,000	368,000	451,000	455,000	378,000	372,000	298,000	148,000	176,000	307,000	176,000
contingent consideration	630,000									9,497,000	4,380,000	4,639,000	4,774,000	4,677,000	4,145,000	2,820,000	738,000	729,000	731,000	640,000
total liabilities	268,620,000	262,351,000	261,057,000	258,536,000	301,033,000	301,594,000	283,193,000	452,246,000	470,659,000	468,721,000	463,128,000	486,395,000	487,591,000	482,908,000	478,070,000	477,905,000	471,898,000	471,142,000	177,160,000	177,279,000	172,433,000	169,707,000	132,327,164	126,119,899	12,818,304	9,591,190	24,728,728	24,395,920	20,887,417	18,073,532	2,964,990	3,316,537	2,631,706	2,377,345	1,965,202	2,164,521	2,833,530	2,292,242	2,606,944	2,727,853	2,468,348	2,197,200	1,972,702	3,022,948				4,014,445	3,051,360	2,335,195	2,287,828	2,062,373	1,966,565	2,484,079	3,603,209	3,929,743	4,595,538	5,083,058	5,278,585	5,524,772	5,470,950	5,691,121	21,585,470	25,816,394	18,474,572	6,348,460	5,897,430	5,059,342	4,652,944	3,461,070	3,461,070
commitments and contingencies
stockholders’ equity:
preferred stock, 0.001 par value...
class a convertible preferred stock - 0.001 par value...
class b convertible preferred stock - 0.001 par value...
class c convertible preferred stock - 0.001 par value...	44,275,000	42,275,000	40,275,000	38,275,000	36,275,000	34,275,000	32,275,000	30,275,000
common stock, 0.001 par value...	50,000	50,000	50,000	50,000	50,000	50,000	49,000	49,000	49,000	49,000	49,000	49,000	48,000		49,000	49,000	50,000		46,000	46,000	45,000		38,984	38,565	37,930	37,340	35,844	35,486	30,678	30,319	29,213	28,451	27,593	25,702	25,218	23,993	23,938	15,128	15,121	12,251	7,247	7,170	5,066	5,026	60,058	60,058	60,038	59,980	59,247	58,146	37,761	37,761	37,761	37,761	28,283	28,133	27,712	27,505	13,683	12,850	8,150	8,137		47,587	43	41,863	41,303	41,198	41,090	40,929	40,929
additional paid-in capital	1,153,304,000	1,152,680,000	1,152,249,000	1,150,700,000	1,147,380,000	1,145,677,000	1,141,122,000	1,138,263,000	1,135,257,000	1,131,183,000	1,127,335,000	1,123,180,000	1,118,172,000	1,114,896,000	1,086,112,000	1,081,747,000	1,102,725,000	1,100,287,000	846,187,000	841,537,000	837,615,000	566,451,000	300,273,819	295,423,521	290,106,664	285,609,022	268,731,704	254,580,262	182,230,799	179,501,577	167,778,827	160,979,798	156,541,327	149,293,947	146,892,442	142,186,654	141,366,712	122,932,859	122,135,591	116,214,522	114,334,637	113,302,694	106,208,008	97,346,137	92,750,244	90,593,704	87,797,202	83,512,399	82,975,314	81,958,609	64,006,050	63,766,258	63,701,610	63,620,774	58,852,206	58,655,108	58,208,140	58,016,991	49,083,611	48,615,847	45,197,150	45,021,097	25,706,272	24,402,380	23,286,723	25,816,588	21,450,070	21,058,527	20,697,994	13,888,094	13,888,094
accumulated deficit	-699,428,000	-688,884,000	-675,235,000	-668,235,000	-769,156,000	-757,175,000	-738,498,000	-739,303,000	-661,314,000	-642,419,000	-580,030,000	-566,761,000	-548,406,000	-542,832,000	-503,787,000	-498,471,000	-489,294,000	-467,541,000	-207,455,000	-200,929,000	-195,540,000	-192,013,000	-180,483,423	-169,065,602	-163,262,856	-159,319,963	-158,372,424	-145,903,877	-143,375,386	-140,988,484	-138,730,220	-136,586,533	-134,115,643	-131,432,883	-129,163,214	-127,183,550	-125,323,093	-119,250,028	-117,065,560	-113,130,846	-109,352,607	-106,592,154	-104,166,691	-97,768,079	-93,928,378	-92,027,710	-88,915,924	-85,876,874	-84,434,964	-82,594,633	-64,594,537	-63,027,526	-61,474,822	-59,929,015	-58,259,616	-56,180,051	-54,149,941	-52,096,087	-50,239,070	-48,782,434	-47,272,613	-45,943,809	-45,377,624	-47,828,293	-39,928,972	-30,634,355	-25,175,059	-23,720,978	-22,151,685	-13,929,204	-13,929,204
accumulated other comprehensive loss	-3,212,000	-3,483,000	-4,068,000	-5,399,000	-15,738,000	-20,929,000	-16,376,000	-29,189,000	-30,077,000	-26,065,000	-34,101,000	-34,488,000	-29,571,000		-42,928,000	-29,176,000															-43,424
total stockholders’ equity	494,989,000	502,638,000	513,271,000	515,391,000	398,811,000	401,898,000	418,572,000	400,095,000	472,190,000	489,023,000	537,528,000	544,255,000	560,518,000	555,838,000	555,721,000	568,424,000	609,434,000	641,828,000	647,226,000	648,029,000	647,275,000	382,698,000	120,036,006	126,656,688	127,304,947	126,281,348	110,329,122	108,750,175	38,906,938	38,546,565	29,034,396	24,421,716	22,453,277	17,886,766	17,754,446	15,027,097	16,067,557	3,697,959	5,085,152	3,095,927	4,990,267	6,718,700	2,047,373									776,493	2,264,549	3,729,520	620,873	2,503,190	4,085,911	5,948,409
total liabilities and stockholders’ equity	763,609,000	764,989,000	774,328,000	773,927,000	699,844,000	703,492,000	701,765,000	852,341,000	942,849,000	957,744,000	1,000,656,000	1,030,650,000	1,048,109,000	1,038,746,000	1,033,791,000	1,046,329,000	1,081,332,000	1,112,970,000	824,386,000	825,308,000	819,708,000	552,405,000	252,363,170	252,776,587	140,123,251	135,872,538	135,057,850	133,146,095	59,794,355	56,620,097	31,999,386	27,738,253	25,084,983	20,264,111	19,719,648	17,191,618	18,901,087	5,990,201	7,692,096	5,823,780	7,458,615	8,915,900	4,020,075									2,838,866	4,231,114	6,213,599	4,224,082	6,432,933	8,681,449	11,031,467
current assets held for sale					108,090,000
long-term assets held for sale
current portion of convertible senior notes, net of discount of 1.1 million and 0.1 million, respectively		185,094,000
current portion of contingent consideration						2,808,000	3,151,000	3,055,000		92,000
current liabilities held for sale					27,657,000
convertible senior notes, net of current portion and discount of 0 and 2.3 million, respectively
contingent consideration, net of current portion		629,000	630,000	628,000	580,000	3,751,000	5,021,000	4,700,000	9,779,000
long-term liabilities held for sale
current portion of convertible senior notes, net of discount of 0.1 million					14,326,000	14,298,000	14,271,000	14,244,000
convertible senior notes, net of current portion and discount of 1.4 million and 2.3 million, respectively			184,799,000
convertible senior notes, net of current portion and discount of 1.7 million and 2.3 million, respectively				184,504,000
convertible senior notes, net of current portion and discount of 2.0 million and 2.3 million, respectively					184,211,000
convertible senior notes, net of current portion and discount of 2.3 million and 7.0 million, respectively						183,919,000
convertible senior notes, net of discount of 2.6 million and 7.0 million, respectively							183,628,000
notes payable							1,238,000	1,258,000	1,305,000	1,335,000	307,000	347,000	364,000		351,000	374,000
convertible senior notes, net of discount of 5.5 million and 7.0 million, respectively								355,665,000

convertible senior notes, net of discount of 6.4 million and 7.0 million, respectively									379,153,000
class c convertible preferred stock, 0.001 par value...									28,275,000	26,275,000	24,275,000	22,275,000	20,275,000	18,275,000	16,275,000	14,275,000	12,275,000	10,275,000	8,275,000	6,275,000	4,275,000	2,844,000
convertible senior notes, net of discount of 7.0 million and 10.1 million, respectively										378,553,000
convertible senior notes, net of discount of 7.6 million and 10.1 million, respectively											377,955,000
convertible senior notes, net of discount of 8.9 million and 10.1 million, respectively												407,992,000
class a convertible preferred stock — 0.001 par value...																																									455	455	455		443	335	250
class b convertible preferred stock — 0.001 par value...																																									535	535	535
convertible senior notes, net of discount of 9.5 million and 10.1 million, respectively													407,349,000
convertible senior notes, net of discount of 10.1 million and 12.7 million, respectively														406,708,000
notes payable, net of discount of 0 million and 0.05 million, respectively														355,000
deferred tax liability														4,929,000	3,037,000	3,745,000	5,002,000	4,018,000	2,356,000	4,843,000	4,626,000	5,882,000	47,943	56,945	29,937	20,935
class a convertible preferred stock, 0.001 par value...																																												455
class b convertible preferred stock, 0.001 par value...																																												162
common stock; 0.001 par value...														48,000				50,000				40,000
accumulated other comprehensive income														-34,549,000			-16,322,000	-1,243,000	173,000	1,100,000	880,000	5,376,000	206,626	260,204	423,209	-45,051	-66,002	38,304	20,847	3,153
convertible senior notes															406,071,000	405,436,000
deferred tax asset																1,597,000	1,734,000
operating lease liabilities																2,656,000	3,466,000	3,542,000	2,820,000	1,523,000	2,002,000	2,231,000	666,929	691,386	813,574	665,901
other liabilities																53,000	53,000
convertible senior notes, net of discount of 12.0 million and 12.7 million, respectively																	404,803,000
note payable, net of discount of 0.03 million and 0.05 million, respectively																	1,048,000
other long-term assets																		419,000	158,000	759,000	752,000	794,000
finance lease liabilities																		61,000	61,000	55,000	60,000	59,000	63,616	57,946	72,207	24,617
convertible senior notes, net of discount of 12.7 million and 3.7 million, respectively																		404,171,000
note payable, net of discount of 0.05 million and 0 million, respectively																		1,086,000
convertible senior notes, net of discount of 3.1 million and 3.7 million, respectively																			111,924,000
note payable, net of discount of 0.1 million and 0, respectively																			4,509,000
convertible senior notes, net of discount of 3.3 million and 3.7 million, respectively																				111,729,000
note payable, net of discount of 0.2 million and 0, respectively																				4,573,000
convertible senior notes, net of discount of 3.5 million and 3.7 million, respectively																					111,536,000
note payable, net of discount of 1.2 million and 0, respectively																					3,497,000
convertible senior notes, net of discount of 3.7 million																						111,344,000
note payable																						4,912,000
convertible senior notes, net of discount of 3.8 million																							111,155,209
convertible senior notes, net of discount of 4.0 million																								110,977,419
revenues																									9,774,075	33,941,900		8,463,588														1,437,028
cost of revenues																									4,516,111	16,590,244		4,125,199														1,000,715
gross margin																									5,257,964	17,351,656		4,338,389														436,313
operating costs and expenses:
general and administrative																									4,030,042	17,465,191		3,258,781
sales and marketing																									3,081,427	13,820,868		2,843,073
engineering and development																									1,732,726	3,740,642		540,933
total operating costs and expenses																									8,844,195	35,026,701		6,642,787														2,258,067
income from operations																									-3,586,231	-17,675,045		-2,304,398														-1,821,754
other income:
interest expense																									-2,451	-1,366,924		-333,910														-601,002
other income																									-321,186	772,065		119,441														-2,707
income before benefit from income taxes																									-3,909,868	-18,269,904		-2,518,867														-2,425,463
benefit for income taxes																									-33,025
net income																									-3,942,893	-18,331,479		-2,528,491														-2,425,463
net income per share																									-0.11	-0.55		-0.08														-0.41
weighted-average shares outstanding – basic and diluted																									37,548,549			31,176,166														6,505,016
convertible note, net of discount of 288,400 as of december 31, 2018
deferred rent liability, net of current portion																														267,415
warrant inducement and repricing expense
total other income																										-594,859
benefit from income taxes																										-61,575		-9,624
weighted-average common shares outstanding – basic and diluted																										33,394,285
convertible note, net of discount of 261,378 and 288,400, respectively																											14,738,622
3
other intangible assets																												5,415,499
convertible note, net of discount of 277,375 and 288,400, respectively																												14,722,625
convertible note, net of discount of 292,800 and 288,400, respectively																													14,707,215
capital lease obligations																														23,191
convertible note, net of discount of 288,400																														14,711,580
capital lease obligations, net of current portion																														33,156
deferred rent liability																															179,707	183,557	189,054	192,202	194,588	196,973	199,359
related-party notes payable and accrued interest, net of discount of 0 and 6,100, respectively																																					563,842
related-party notes payable and accrued interest, net of discount of 12,400 and 24,900, respectively																																						739,677
related-party notes payable, net of current portion																																								554,275				26,452
related-party notes payable and accrued interest, net of discount of 18,700 and 24,900, respectively																																							863,557
notes payable and accrued interest, net of discount of 221,400 at march 31, 2015																																												535,507
related-party notes payable and accrued interest, net of discount of 24,900 and 259,600, respectively																																								392,898
stockholders’ equity
other current assets																																									288,965	188,673	263,227	97,337	122,413	85,312	81,421	196,505	102,718	40,685	57,030	38,630	37,585	65,970	134,644	251,319	387,905	528,045	213,303	63,315	102,099	104,014
related-party notes payable and accrued interest, net of discount of 64,000 and 259,600, respectively																																									981,992
related-party notes payable and accrued interest, net of discount of 129,400 and 259,600, respectively																																										956,557
selling, general and administrative																																										2,157,771
research and development																																										100,296
preferred stock beneficial conversion charge
undeclared cumulative preferred dividends																																										-239,388
net income attributable to common stockholders																																										-2,664,851
related-party notes payable and accrued interest, net of discount of 194,900 and 259,600, respectively																																											970,110
deposits and other assets																																															9,358	9,358	9,358	19,744	19,744	19,744	19,744	19,744	19,744	9,358	9,358	9,358
liabilities and stockholders’ deficit
convertible debentures payable and accrued interest, net of discount of 184,800 at march 31, 2014
related-party notes payable and accrued interest, net of discount of 259,600 at march 31, 2015																																												976,581
stockholders’ (deficit) equity:
total stockholders’ deficit																																												-416,299	-1,117,633	-1,373,613	-1,058,434	-2,304,495	-1,400,403	-577,878									-1,141,776	-153,737	-2,067,313	-914,575	-19,621,336	-23,378,326	-16,598,335	-4,775,904	-3,683,686	-2,621,253	-1,412,601	-181	-181
total liabilities and stockholders’ deficit																																												2,606,649	1,866,582	1,205,318	1,324,903	1,709,950	1,650,957	1,757,317									4,136,809	5,371,035	3,403,637	4,776,546
notes payable and accrued interest, net of discount of 274,500 at december 31, 2014																																													343,432
convertible debentures payable and accrued interest, net of discount of 184,750 at march 31, 2014
related party notes payable and accrued interest																																													1,309,682
current portion of related party notes payable																																														1,326,188	1,342,334	1,358,120	96,000	96,000	96,000	104,000	96,000	96,000	96,000	96,000	96,000	102,000	140,000	146,000	150,000	150,000	160,000	150,000	150,000	150,000	150,000	150,000	150,000	150,000	150,000
convertible debentures payable and accrued interest, net of discount of 184,750 in 2014																																																1,622,359
derivative liabilities																																																	3	1,199	9,622	3,510	17,999	37,334	47,344	107,529	122,214	156,497	57,503	91,490	217,835	334	13,740,633	18,404,578
related party notes payable and accrued interest, net of current portion																																																	1,277,546	1,292,612	1,335,650	1,349,286	1,370,542	1,375,448	1,387,994	1,400,180	1,412,006	1,423,412	1,441,968	1,451,854	1,463,280	1,478,256	1,492,792	1,506,898	1,520,554		1,546,516	1,558,822	1,570,678
accounts payable and accrued expenses																																																	895,902	602,957	678,091	460,789	353,813	401,399	723,635	563,910	448,658	506,887	407,498
convertible debentures payable and accrued interest, net of discount																																																	390,471
stockholders’ deficit:
convertible debentures payable and accrued interest
restricted cash																																																						251,368			91,317	91,169	91,024	90,858	90,630	90,404	90,030	102,115	101,650	101,053	100,477	208,196	205,920	203,670	203,670
liabilities and stockholders’ (deficit) equity
convertible debentures payable and accrued interest, net of discount of 0 at december 31, 2012 and 8,843 at march 31, 2012
total stockholders’ (deficit) equity																																																			-550,726
total liabilities and stockholders’ (deficit) equity																																																			1,737,102
convertible debentures payable and accrued interest, net of discount of 0 at september 30, 2012 and 8,843 at march 31, 2012
convertible debentures payable and accrued interest, net of discount of 0 at june 30, 2012 and 8,843 at march 31, 2012
commitments and contingencies stockholders’ equity:
current portion of convertible debentures payable and accrued interest, net of discount of 8,843 in 2012 and 197,226 in 2011, respectively																																																						337,902
line of credit and accrued interest																																																									90,375	90,388	90,388	90,375	90,375	90,388	90,388	90,310	90,300	90,310	90,334	93,307	103,349	115,943	115,943
convertible debentures payable, net of current portion and discount of 0 in 2012 and 8,842 in 2011, respectively
current portion of convertible debentures payable, net of discount of 35,524 at december 31, 2011 and 197,226 at march 31, 2011, respectively																																																							795,044
convertible debentures payable, net of current portion and discount of 0 at december 31, 2011 and 8,842 at march 31, 2011, respectively
current portion of convertible debentures payable, net of discount of 78,138 at september 30, 2011 and 197,226 at march 31, 2011, respectively																																																								1,352,430
convertible debentures payable, net of current portion and discount of 0 at september 30, 2011 and 8,842 at march 31, 2011, respectively
current portion of convertible debentures payable, net of discount of 135,696 at june 30, 2011 and 197,226 at march 31, 2011, respectively																																																									1,894,872
convertible debentures payable, net of current portion and discount of 0 at june 30, 2011 and 8,842 at march 31, 2011, respectively
current portion of convertible debentures payable, net of discount of 197,226 in 2011 and 0 in 2010																																																										1,979,402
convertible debentures payable, net of current portion and discount of 8,842 in 2011 and 728,109 in 2010, respectively																																																										421,726
current portion of convertible debentures payable, net of discount																																																											1,704,065	1,014,420	345,193
convertible debentures payable, net of current portion and discount																																																											1,184,146	1,738,520	2,278,831
restricted cash — investor funds																																																												255,000
deferred financing costs																																																												54,156	10,000		233,591	193,773	51,286	3,600	82,550	93,317	104,084	325,769	325,769
accounts payable																																																												502,543	604,141	823,653	339,436	393,701	321,326	218,433	331,964	248,805	235,859	234,298	234,298
deposits from investors																																																												255,000
inventory
accrued warranty costs																																																																	18,743	18,743	24,368	24,368	24,368	29,993	29,993
convertible notes payable, net of discount of 13,586 in 2009
current portion of convertible debentures payable and accrued interest, net of discount of 0 in 2010 and 662,583 in 2009																																																														200,000
current portion of note payable to former officer																																																																96,000	108,000	90,000
other accrued expenses
note payable to former officer and accrued interest, net of current portion																																																																36,476	52,064	67,688
convertible debentures payable, net of current portion and discount of 728,109 in 2010 and 2,227,205 in 2009, respectively																																																														2,302,459
fixed assets																																																															591,094	613,755	180,922	189,301	204,469	216,341	208,720	193,852	193,852
other assets																																																																	30,367	61,294	104,577	147,860	178,787	209,714	209,714
accrued expenses																																																															151,363	370,984	90,640	90,547	94,465	94,803	104,446	95,048	95,048
accrued salaries and related																																																															226,833	244,730	221,108	206,180	197,416	129,878	133,749	138,103	138,103
convertible notes payable net of discount of 513,160 (unaudited) at december 31, 2009 and 13,586 at march 31, 2009																																																															930,304
current portion of convertible notes payable and accrued interest, net of discount of 1,662,177 (unaudited) at december 31, 2009 and 662,583 at march 31, 2009																																																															4,319,248
current portion of note payable to former officer and accrued interest																																																															134,473
convertible notes payable, net of current portion and discount of 5,981,425 at december 31, 2009 and 6,681,629 at march 31, 2009
common stock, 0.01 par value...																																																															50,016
convertible notes payable and accrued interest, net of discount of 775,960 (unaudited) at september 30, 2009 and 13,586 at march 31, 2009																																																																639,647
current portion of convertible notes payable and accrued interest, net of discount of 2,468,355 (unaudited) at september 30, 2009 and 662,583 at march 31, 2009																																																																3,883,070
convertible notes payable, net of current portion and discount of 6,351,425 at september 30, 2009 and 6,681,629 at march 31, 2009
convertible notes payable and accrued interest, net of discount of 754,486 at june 30, 2009 and 13,586 at march 31, 2009																																																																	242,552
current portion of convertible notes payable and accrued interest, net of discount of 3,514,107 at june 30, 2009 and 662,583 at march 31, 2009																																																																	1,994,748
liability for derivative instruments																																																																	13,664,537
convertible notes payable, net of current portion and discount of 5,968,629 at june 30, 2009 and 6,681,629 at march 31, 2009
convertible notes payable, net of discount of 13,586																																																																		46,414
current portion of convertible debentures payable and accrued interest, net of discount of 662,583																																																																		3,836,385
current portion of note payable																																																																						12,000	12,000
related party notes and accrued interest payable, net of current portion																																																																		1,533,760				1,582,084	1,582,084
convertible debentures payable, net of current portion of 4,454,424
current portion of convertible notes payable and accrued interest, net of discount of 229,164 at december 31, 2008 and 1,039,844 at march 31, 2008																																																																			2,552,335
current portion of note payable to officer																																																																			84,000	72,000	72,000	72,000	72,000
convertible notes payable, net of current portion and discount of 3,069,687 at december 31, 2008 and 2,482,513 at march 31, 2008																																																																			742,746
note payable to officer and accrued interest, net of current portion																																																																			83,286	98,772	114,058
current portion of convertible notes payable and accrued interest, net of discount of 907,027 at september 30, 2008 and 1,039,844 at march 31, 2008																																																																				2,588,587
convertible notes payable, net of current portion and discount of 3,073,318 at september 30, 2008 and 2,482,513 at march 31, 2008
current portion of convertible notes payable and accrued interest, net of discount of 860,886 at june 30, 2008 and 1,039,844 at march 31, 2008																																																																					2,144,437
convertible notes payable, net of current portion and discount of 2,760,796 at june 30, 2008 and 2,482,513 at march 31, 2008
convertible notes payable and accrued interest, net of discount of 0
current portion of convertible notes payable and accrued interest, net of discount of 1,039,844																																																																						902,486	902,486
convertible notes payable, net of current portion of 1,936,884
note payable to officer, net of current portion																																																																						129,115	129,115
note payable, net of current portion

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30

cash flows from operating activities:
net loss	-10,544,000			-11,981,000	-18,677,000	805,000	-77,989,000	-18,895,000	-62,389,000			-5,574,000	-9,436,000	-5,316,000	-9,177,000	-13,404,000	-260,086,000	-6,526,000	-5,389,000	-3,527,000	-11,529,540	-11,417,821	-5,802,746	-3,942,893	-947,539	-12,468,547	-2,528,491	-2,386,902	-2,258,264	-2,143,687	-2,470,890	-2,682,760	-2,269,669	-1,979,664	-1,860,457	-1,789,211	-2,184,468	-3,934,714	-2,710,184	-2,760,453	-2,425,463	-1,924,264	-1,937,132	-1,407,758	-1,384,759	-2,297,264	-1,441,910	-1,840,331	-14,959,648	-1,323,537	-1,716,911	-1,567,011	-1,552,704	-1,545,807	-1,669,399	-2,079,565	-2,030,110	-2,053,854	-1,857,017	-1,456,636	-1,509,821	-1,328,804	-566,185	2,450,669			-5,459,296	-1,454,081	-1,569,293	-8,222,481
adjustments to reconcile net loss to net cash from operating activities:
depreciation and amortization	6,402,000	6,415,000	7,296,000	7,646,000	7,894,000	7,836,000	7,558,000	7,469,000	7,449,000	6,911,000	6,723,000	6,404,000	6,134,000	5,786,000	5,480,000	5,365,000	5,303,000	5,157,000	4,950,000	4,837,000	7,369,913	830,377	844,281	824,429	825,051	792,916	496,690	300,565	264,746	214,000	191,359	187,834	172,851	184,075	176,354	131,551	100,770	97,847	72,904	72,298	48,353	45,673	42,712	50,040	50,046	55,140	53,401	79,199	89,547	89,443	86,697	90,331	121,902	95,029	92,292	88,686	83,160	78,891	69,182	66,599	56,761	52,935	48,605	38,623	31,363	31,502	29,623	21,807	15,923	14,631
amortization of debt discount	296,000	294,000	311,000	320,000	318,000	424,000	597,000	601,000	598,000	645,000	642,000	641,000	651,000	644,000	643,000	643,000	500,000	240,000	232,000	264,000	189,396	187,499			241,630	15,997	15,410	15,383																								0	0	8,843	26,681	42,614	57,558	70,372	136,289	135,271	128,916	121,565	1,610,799	1,068,978	2,181,878	1,555,691	583,007	681,523	540,311	418,275
non-cash operating lease expense	1,237,000	1,267,000	2,126,000	1,911,000	1,379,000	1,565,000	1,466,000	1,360,000	1,700,000	1,122,000	1,182,000	1,099,000
unrealized loss on investments in equity securities	1,062,000		46,000	-659,000	2,344,000	-2,471,000	348,000	678,000	-3,563,000			-1,510,000	-1,030,000	3,880,000	3,648,000	4,908,000	1,078,000			263,000	-407,238				13,824
realized loss on available-for-sale investments	1,044,000			851,000	102,000	5,957,000	448,000	-2,416,000		-7,000	-17,000	86,000		33,000	31,000	49,000		-8,000	45,000	40,000
stock-based compensation expense	2,395,000	2,526,000	2,375,000	3,700,000	4,413,000	4,838,000	4,997,000	5,456,000	5,848,000	5,976,000	5,800,000	5,184,000	5,333,000	5,366,000	5,258,000	4,125,000	4,182,000	4,148,000	4,025,000	2,990,000	2,561,454	2,432,671	2,301,497	1,620,378	1,610,357	1,945,775	1,991,755	1,413,735		1,498,663	1,445,729	1,049,510		964,857	794,559	770,442	799,797	749,196			637,635	480,377	316,486	210,768	187,358	167,094
loss on disposal of property and equipment	30,000	44,000	101,000	4,000	89,000	57,000	107,000	131,000	677,000	87,000	113,000	77,000	226,000	270,000	212,000	92,000	417,000	12,000	42,000	71,000	170,108	92,556	40,743	80,593		58,618	52,651	47,603	225,848	109,173	41,861	20,585	109,808	26,382	32,602	17,238	7,249	9,123	131,465	4,430
change in credit losses	7,000	109,000	79,000	-31,000	-260,000	36,000	-117,000	99,000		-2,000	-30,000	-103,000
excess and obsolete inventory	98,000	146,000	-181,000	145,000									105,000	0
change in contingent consideration	15,000	-1,000	-23,000	-5,183,000	-518,000	412,000	-2,034,000	293,000	-685,000	-137,000	-114,000	46,000
changes in operating assets and liabilities:
accounts receivable	-5,733,000	-1,883,000	-6,723,000	778,000	-3,074,000	-2,633,000	1,121,000	437,000	2,585,000	-16,000	2,518,000	-1,414,000	4,170,000	-4,016,000	-7,631,000	3,340,000	-706,000	-974,000	-377,000	-5,213,000	-1,867,710	-774,772	-929,195	954,677	398,999	-1,401,375	-1,929,567	-664,667	-318,907	389,630	-1,268,700	-760,428	-161,350	-223,405	215,482	-272,370	-10,326	-1,691	-406,717	84,160	23,825	-171,077	-184,488	621	78,971	28,309	94,986	-248,018	-29,967	-140,605	-15,960	-30,769	-25,602	1,358	-62,416	27,679	-35,442	-20,151	-19,870	23,016	-26,124	48,220	-71,006	-2,757	282	-5,009	2,276	-349	-2,422	19,360
inventories	1,319,000	-421,000	638,000	-2,305,000	536,000	284,000	1,319,000	1,113,000	3,080,000	-325,000	-2,486,000	1,239,000	-3,025,000	-1,703,000	-1,761,000	-7,715,000	-2,999,000	-1,842,000	-150,000	-988,000	1,324,661	61,754	-73,788	9,373	-123,041	-44,482	-79,348	-6,576	-90,215	-33,009	24,636	-7,130	-24,542	-17,633	-1,661	18,539	1,353	-13,743	-55,197	26,350	-6,500	-35,124	-2,722	-8,154	-20,203	-8,898	305	13,297	9,559	-13,652	16,247	460	-8,413	4,248	-4,624	-4,451	2,284	-739	15,639					0	63,327	17,685	2,963	-111,859	-226,309	-73,084
prepaid expenses and other current assets	2,223,000	1,333,000	2,794,000	394,000	-2,603,000	1,835,000	-207,000	-1,174,000	2,195,000	-3,549,000	1,522,000	-271,000	-179,000	-376,000	-1,064,000	21,000	334,000	3,234,000	6,033,000	-6,545,000	-7,671,519	-53,684	110,537	94,666	-140,850	-429,138	215,353	10,049				-25,035	-284,065	44,586	12,490	-34,500
deposits	16,000	-15,000	-3,000	-167,000	-1,638,000	204,000	0	-9,000	-11,000	-455,000	1,000	-198,000	-69,000	-18,000			1,000	-20,000	1,000	229,000	-53,549	-772	-51,678	-46,001	-30,613	683
operating lease liabilities	-1,212,000	-1,032,000	-1,647,000	-1,288,000	-1,059,000	-1,527,000	-1,452,000	-1,302,000	-1,586,000	-907,000	-1,098,000	-1,004,000
accounts payable and other accrued expenses	-596,000	-129,000	-1,811,000	-783,000	2,946,000	-728,000	-2,558,000	264,000	-2,730,000	2,838,000	402,000	-3,276,000	-3,311,000	1,111,000	-2,176,000	-2,107,000	1,936,000	2,649,000	-5,515,000	532,000	-2,120,123	3,215,353	3,084,458	65,312	-697,790	-444,381	1,053,313	659,335	-223,192	-333,521	856,444	105,343	-77,703	-4,681	-123,881	329,514	72,321	-160,477	-37,317	453,243	144,813	-247,509	54,889	10,381	164,096	-20,228
accrued compensation and related expenses	4,061,000	1,359,000	-3,201,000	1,633,000	2,044,000	438,000	-3,349,000	2,719,000	871,000	1,765,000	-1,714,000	1,962,000	-351,000	363,000	-3,722,000	2,141,000	1,277,000	1,906,000	-1,465,000	804,000	2,491,967	702,567	-819,287	767,753	336,566	32,897	-219,344	491,123	377,357	-18,026	-171,613	149,018	296,721	30,468	184,704	-5,413	-8,609	-131,910	168,733	10,191	-55,609	-285,460	108,076	67,977	47,644	47,727	62,850	49,011	61,982	63,013	48,967	23,677	16,577	-107,785	-317,196	143,498	-121,719	128,667	149,729	18,447
deferred revenue	1,379,000	-231,000	-180,000	699,000	44,000	-246,000	-439,000	462,000	-299,000	653,000	-82,000	570,000	-110,000	-269,000	-121,000	-30,000	239,000	-151,000	-35,000	49,000	-178,108	-93,297	-10,878	-26,717	-55,734	201,761	-36,433	-28,397
net deferred tax liability	236,000	-299,000	1,103,000	-26,000	6,000			-551,000		30,000	-466,000	246,000
net cash from operating activities	3,735,000	2,188,000	-7,345,000	-4,342,000	-5,480,000	447,000	-8,025,000	-3,265,000	2,482,000	-1,959,000	-4,054,000	2,774,000	3,654,000	982,000	-7,011,000	524,000	2,614,000	8,876,000	2,627,000	-5,991,000	-9,713,157	-4,843,235	-1,368,968	1,059,360	741,021	-813,395	-1,061,883	-189,603	-359,406	-664,226	-1,265,095	-1,063,653	-1,220,016	-965,015	-568,172	-829,923	-1,534,360	-1,449,933	-1,969,641	-1,393,693	-1,068,067	-1,874,289	-1,292,409	-1,060,711	-857,533	-917,049	-1,221,253	-841,575	-1,146,840	-1,170,991	-1,106,956	-1,022,319	-1,231,052	-1,424,817	-2,106,672	-1,482,148	-1,644,687	-1,546,627	-1,172,205	-1,406,728	-985,026	-1,247,452	-911,666	-796,196	-639,537	-505,960	-544,008	-458,440	-889,108	-694,914
capital expenditures	-9,981,000	-3,453,000	-4,351,000	-3,168,000	-5,219,000	-4,239,000	-3,790,000	-4,006,000	-11,573,000	-8,969,000	-8,674,000	-9,569,000	-7,857,000	-5,190,000	-4,815,000	-4,245,000	-8,326,000	-8,851,000	-3,894,000	-2,811,000	-3,799,197	-2,576,652	-1,945,992	-596,159	-1,146,898	-1,610,798	-1,457,120	-1,121,025	-1,081,897	-863,049	-699,540	-269,543	-485,260	-207,350	-391,239	-631,082	-67,340	-193,857	-405,258	-378,591	-225,787	-109,615	-2,279	0	0		655	-2,045	-6,237	-131,259	-85,035	-24,386	-2,908	-43,871	-18,784	-121,051	-78,329	-44,477	-42,333	-27,988	-60,228	-210,851	0	0	0	0	0	0	0	0
free cash flows	-6,246,000	-1,265,000	-11,696,000	-7,510,000	-10,699,000	-3,792,000	-11,815,000	-7,271,000	-9,091,000	-10,928,000	-12,728,000	-6,795,000	-4,203,000	-4,208,000	-11,826,000	-3,721,000	-5,712,000	25,000	-1,267,000	-8,802,000	-13,512,354	-7,419,887	-3,314,960	463,201	-405,877	-2,424,193	-2,519,003	-1,310,628	-1,441,303	-1,527,275	-1,964,635	-1,333,196	-1,705,276	-1,172,365	-959,411	-1,461,005	-1,601,700	-1,643,790	-2,374,899	-1,772,284	-1,293,854	-1,983,904	-1,294,688	-1,060,711	-857,533		-1,220,598	-843,620	-1,153,077	-1,302,250	-1,191,991	-1,046,705	-1,233,960	-1,468,688	-2,125,456	-1,603,199	-1,723,016	-1,591,104	-1,214,538	-1,434,716	-1,045,254	-1,458,303	-911,666	-796,196	-639,537	-505,960	-544,008	-458,440	-889,108	-694,914
cash flows from investing activities:
purchases of property and equipment	-9,981,000	-3,453,000	-4,351,000	-3,168,000	-5,219,000	-4,239,000	-3,790,000	-4,006,000	-11,573,000	-8,969,000	-8,674,000	-9,569,000	-7,857,000	-5,190,000	-4,815,000	-4,245,000	-8,326,000	-8,851,000	-3,894,000	-2,811,000	-3,799,197	-2,576,652	-1,945,992	-596,159	-1,146,898	-1,610,798	-1,457,120	-1,121,025	-1,081,897	-863,049	-699,540	-269,543	-485,260	-207,350	-391,239	-631,082	-67,340	-193,857	-405,258	-378,591	-225,787	-109,615	-2,279	0			655	-2,045	-6,237	-131,259	-85,035	-24,386	-2,908	-43,871	-18,784	-121,051	-78,329	-44,477	-42,333	-27,988	-60,228	-210,851
software development costs		-587,000	-1,507,000	-555,000	-125,000	-687,000	-1,631,000	-443,000	-414,000	-2,296,000	-2,071,000	-463,000	-511,000	-401,000	-351,000	-213,000	-113,000	-308,000	-256,000	-193,000
sales/maturities of short-term investments	29,000,000	18,588,000	26,001,000	10,000,000	9,138,000	159,753,000	54,975,000	25,250,000	47,500,000	30,000,000	44,637,000	7,850,000	24,023,000	23,075,000	48,760,000	36,000,000	3,000,000	33,000,000	5,000,000	3,000,000	6,956,756	122,997,378	3,000,000	16,278,866
patent and trademark costs	-301,000	-242,000	-343,000	-355,000	-297,000	-163,000	-349,000	-318,000	-255,000	-225,000	-214,000	-177,000	-96,000	-160,000	-220,000	-138,000	-105,000	-41,000	-61,000	-48,000	-83,704	-41,362	-45,080	-29,854	-25,138	-5,441	-22,541	-20,488	-12,398	-7,004	-11,822	-15,350
net cash from investing activities	18,718,000	14,306,000	230,039,000	5,922,000	3,479,000	153,570,000	13,321,000	6,445,000	-14,760,000	18,510,000	33,678,000	-1,383,000	7,124,000	-5,865,000	-63,990,000	3,050,000	-195,971,000	-27,008,000	-30,905,000	-215,370,000	-383,059,950	120,338,188	-119,047,756	-542,482	789,874	-36,645,504	-21,419,511	-5,651,974	-1,102,523	-10,785,444	-711,362	-284,893	-519,373	-234,155	-405,768	-641,281	-72,340	-193,857	-405,258	-378,591	-225,787	-109,615	-2,279	0			655	-2,045	-6,237	-131,259	-107,517	-24,386	-2,908	-43,871	-18,991	-166,717	-132,539	-69,814	-70,904	-49,525	-89,789	-255,232			-6,353	-27,786		54,560	-23,544	-30,132
cash flows from financing activities:
proceeds from exercise of stock options	229,000	1,023,000	2,947,000	3,000	2,142,000	21,000	9,000	618,000	-2,000	180,000	1,208,000	92,000		999,000																																			0	100,000
repayment of notes payable	-35,000	-41,000	-43,000	-37,000	-28,000	-41,000	-36,000	-36,000	-45,000	-15,000	-21,000	10,000		-1,430,000																									0	0	0	-741,377
repayment of finance lease liabilities	-109,000	-105,000	-165,000	-155,000	-102,000	-162,000	-74,000	-70,000	-79,000	-53,000	-39,000	-31,000	-36,000			-13,000	-16,000	-12,000	-14,000	-18,000	-18,289	-19,470	-17,942	-14,299	-5,930	-5,835	-5,748	-5,678
net cash from financing activities	85,000	-2,868,000	-15,864,000	-189,000	2,012,000	-155,291,000	-8,764,000	512,000	-126,000	-24,891,000	1,148,000	71,000	-5,306,000	-459,000	-25,360,000	-8,049,000	288,575,000	2,491,000	1,883,000	271,393,000	266,443,311	2,150,581	114,127,553	2,863,555	1,092,665	1,410,416	70,356,768	1,290,420	24,936,013	5,301,128	2,993,600	5,300,351	1,384,066	3,742,156	-704,394	11,479,535	-360,992	3,376,984	-80,000	-40,000	5,967,644	2,964,637	1,925,952	1,731,290	858,222	717,973	1,370,209	531,121	1,458,016	966,676	1,192,470	-37,822	-67,973	-177,280	3,947,109	-508,500	-325,924	-605,398	7,810,576			-30,000	4,002,863	318,862	1,209,726	840,910	17,999	-39,000	-58,000	683,713
effect of exchange rates on cash and cash equivalents	-120,000	-1,231,000	-10,775,000	681,000	613,000	-519,000	263,000	-375,000	-723,000	499,000	-1,996,000	481,000		-968,000	-1,053,000	-178,000		-1,036,000	1,258,000	-1,411,000		15,511	-7,245	7,251		-8,576	-5,147	-3,982
net change in cash and cash equivalents	22,418,000	12,395,000	196,055,000	2,072,000	624,000	-1,793,000	-3,205,000	3,317,000	-13,127,000	-7,841,000	28,776,000	1,943,000	5,871,000	-6,310,000	-97,414,000	-4,653,000	95,421,000	-16,677,000	-25,137,000	48,621,000	-125,114,313	117,661,045	-6,296,416	3,387,684	2,649,616	-36,057,059	47,870,227	-4,555,139	23,477,481	-6,161,493	1,017,143	3,951,805	-355,323	2,542,986	-1,678,334	10,008,331	-1,733,428.498	1,733,194	-2,454,899	-1,812,284	4,673,790	980,733	631,264					-312,499	304,939	-335,574	-22,003	-1,084,527	-1,301,933	-1,645,968	1,821,446	-2,157,365	-2,103,150	-2,221,839	6,567,467	-1,034,769	1,648,543	-1,532,684	2,982,578	-473,450	563,836	307,164	-526,408	-442,880	-970,652	-41,333
cash and cash equivalents — beginning of period	250,494,000	0	0	45,289,000	0	0	0	46,346,000	0	0	0	36,595,000		0	0	139,101,000		0	0	36,873,000		0	0	47,234,770		0	0	37,327,125		0	0	15,042,189	0	0	0	4,524,529	0	2,792,526		0	0	1,405,186		0	0	369,581
cash and cash equivalents — end of period	272,912,000	12,395,000	196,055,000	47,361,000	624,000	-1,793,000	-3,205,000	49,663,000	-13,127,000	-7,841,000	28,776,000	38,538,000		-6,310,000	-97,414,000	134,448,000		-16,677,000	-25,137,000	85,494,000		117,661,045	-6,296,416	50,622,454		-36,057,059	47,870,227	32,771,986		-6,161,493	1,017,143	18,993,994	-355,323	2,542,986	-1,678,334	14,532,860	-1,967,692	4,525,720		-1,812,284	4,673,790	2,385,919		670,579	-67,162	170,505
reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:
cash and cash equivalents from continuing operations	250,494,000	0	0	34,137,000
cash and cash equivalents from discontinued operations		0	0	11,152,000
total cash and cash equivalents — beginning of period	250,494,000	0	0	45,289,000
total cash and cash equivalents — end of period	272,912,000	12,395,000	196,055,000	47,361,000
supplemental disclosure of cash flow information:
cash paid for interest	28,000	4,000	885,000	36,000	2,064,000	-982,000	1,573,000	38,000	1,607,000	67,000
cash paid for income taxes	502,000	308,000	218,000	408,000	243,000	472,000	290,000	417,000	511,000	-152,000	670,000	433,000
supplemental disclosure of non-cash financing activities:
operating lease right-of-use assets and operating lease liabilities	947,000	3,292,000	205,000	2,286,000	19,446,000	1,357,000			1,528,000	3,978,000	1,167,000	4,436,000
net unrealized gain on available-for-sale debt securities	18,000	163,000	365,000	808,000	-359,000	1,964,000	994,000	261,000	3,666,000	624,000
reclassification of realized gain on available-for-sale debt securities to earnings	1,096,000	713,000	1,349,000	854,000	-400,000	-7,843,000	3,933,000	-2,314,000	-4,397,000								37,000	28,000	-68,000	30,000	-15,800	-7,752	26,158	394	1,379	8,963	9,748	3,098
paid-in-kind preferred stock dividend	2,000,000													2,000,000	2,000,000	2,000,000
intangible assets included in property and equipment	3,633,000
fixed asset purchases included in accounts payable and accrued liabilities	1,604,000
contingent consideration reclassed to accounts payable and accrued liabilities		12,000	36,000	833,000
purchase of equipment through finance lease obligation	57,000	11,000	338,000	39,000
net income		-3,254,000																																																																363,276
adjustments to reconcile net income to net cash from operating activities:
impairment loss					0	0
unrealized gain on investments in equity securities																							-192,163	-144,415			-43,803	-31,545
realized loss on investments in equity securities					0																285,228	0	11,597	793,175
gain on extinguishment of debt					0	-17,326,000
gain on divested business		-3,385,000

purchases of short-term investments					0	-799,000	-35,884,000	-14,038,000					-8,435,000	-18,742,000	-106,257,000	-30,354,000	-190,427,000	-50,287,000	-26,675,000	-215,318,000	-22,442,805	-41,176	-120,056,684	-16,195,335	-151,034	-37,024,265	-1,010,199	-5,010,461	-8,228
proceeds from divested business		0
proceeds from related party loans
acquisitions
repurchase of common stock		-3,745,000											-4,611,000	0	-25,000,000	-8,349,000
cash paid for repurchase of 2026 convertible senior notes
repayment of 2025 convertible senior notes		0
paid-in-kind preferred stock dividend, including beneficial conversion feature		2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000
fixed assets included in accounts payable and accrued liabilities		-40,000	80,000	189,000	76,000	-437,000	-78,000	542,000	-130,000	-250,000	115,000	707,000	522,000	84,000	-152,000	549,000	-142,000	-2,314,000	3,670,000	198,000	172,154	-322,568	41,280	608,134	102,402
realized gain on available-for-sale investments																						6,940	-5,958	-10,934
gain on insurance settlement									0	0	0	-2,642,000	0
insurance proceeds for operations									0	0	0	1,212,000	3,454,000	118,000	3,311,000	3,000,000
insurance proceeds for loss of fixed assets									0	0	0	976,000	0	0	1,000,000	2,000,000
cash paid for acquisitions
cash paid for repurchase of 2026 senior notes									0
cash paid to repurchase of 2026 senior notes						-155,109,000
net deferred tax asset
goodwill impairment
realized loss on available-for-sale debt securities
loss on extinguishment of debt																																																																			4,035,359	0	6,804,311.059	6,902.941
change in expected credit losses
net deferred tax (asset) liability
proceeds from issuance of series c convertible preferred stock, net of issuance costs
proceeds from public offering, net of offering costs
proceeds from issuance of convertible senior notes																					0	0
purchase of equipment through finance lease obligations																					484	0
common stock issued for conversion of debt and accrued interest
receivable included in prepaid expenses and other current assets
common stock issued for cell&co acquisition														0
unrealized (gain) loss on investments in equity securities
reclassification of realized loss on available-for-sale debt securities to earnings											-730,000	99,000		0	-79,000	33,000
net unrealized loss on available-for-sale debt securities												-3,675,000
provision for bad debt													221,000	-22,000	4,000	31,000	-237,000	48,000	152,000	63,000	133,021	30,003	30,000	3,976	0	43			-27,535	32,075			10	10,000			25,365	7,425	2,503	1,963			2,248	0
changes in operating assets and liabilities, net of effects of acquisition:
change in operating lease right-of-use assets and lease liabilities													253,000	289,000	22,000	5,000	259,000	83,000	160,000	60,000	72,938	47,577	6,499	6,986	3,238	5,439	-5,668	-9,309
proceeds from exercise of stock options and warrants																313,000	3,009,000	2,503,000	1,897,000	1,586,000	1,076,105	2,418,046	3,015,995	2,877,854	1,078,847	1,412,979	1,555,070	1,315,846	417,952	1,950,823	2,993,600	658,544							0	0	0	10,881	80,978	0	0	11,631	146,889
proceeds from issuance of common stock, net of issuance costs
repayment of note payable																																																																			0	0	0	-12,000
payment of deferred financing costs																					495	-247,995				0	0	-19,748																								-5,822				0	-27,500	-130,770		-1,897				-73,180	-73,700	-55,590				-191,875
effect of exchange rate changes on cash and cash equivalents																													3,397
cash and cash equivalents — beginning of year
cash and cash equivalents — end of year
supplemental disclosure of non-cash investing and financing activities:
contingent consideration
deferred tax (asset) liability														-488,000
mve net working capital settlement
acquisitions, net of cash acquired
proceeds from public offering, net of 17.7 million in offering costs																		0	0	269,825,000
conversion of series c preferred stock to common stock																		0	0	765,000
cost of series c preferred stock conversion included in additional paid-in-capital and accounts payable and accrued liabilities																		0	0	1,800,000
cryopdp goodwill adjustment included in deferred tax liability																		53,000	-517,000	1,394,000
cryopdp goodwill adjustment included in fixed assets																		-1,000	0	71,000
fair value adjustment of ctsa contingent consideration included in goodwill and contingent consideration
note valuation adjustment included in notes payable and goodwill
net unrealized loss on available-for-sale securities														-6,538,000	-33,439,000	14,065,000
acquisition of cell&co
acquisition of ctsa and f-airgate																		-21,000
repayment of capital lease obligation
mve estimated working capital adjustment included in goodwill and accounts payable
deferred tax liability																60,000		768,000	25,000	80,000		-9,002	27,008	9,002
mve goodwill adjustment included in fixed assets
note valuation adjustment included in note payable and goodwill																		9,000	-991,000	1,266,000
interest expense on convertible note settled by issuance of common stock
accelerated stock-based compensation expense																									-1,227,890
proceeds from the issuance of convertible senior notes
fair value adjustment of ctsa contingent consideration included in goodwill and contingent consideration accrual
net unrealized gain on available-for-sale securities																		-366,000	-1,946,000	768,000		-85,103	-135,178	470,924
purchase of equipment through capital lease obligations																								202,619
financing costs included in accounts payable and accrued liabilities
convertible debt costs included in accounts payable and accrued liabilities
cash paid for acquisition																									112,944	0
proceeds from june 2019 public offering, net of offering costs																										3,272
realized gain on treasury notes and bills																									-19,189	-32,573
warrant inducement and repricing expense																													0	0	0	899,410
property and equipment disposal costs
accrued interest																																	0	0	0	-1,843	-2,006	9,018	6,027	0	-18,988	-1,186	21,524	10,466	7,854	18,110	22,674	8,961	46,340	30,063	19,933	10,364	10,744	-1,483	24,031	11,814	11,799	12,581	13,444	14,127	14,574	15,011	11,679	45,826	121,919	156,406	151,863	45,235	16,354	118,164
maturities of short-term investments																									2,000,000	1,995,000
proceeds from issuance of convertible debt																																															1,352,000	591,000	1,657,150	958,151
proceeds from issuance of common stock, net of costs
proceeds from tender offer, net of offering costs
proceeds from the atm, net of offering costs
leasehold improvements paid by tenant allowance
proceeds from february 2018 tender offer, net of offering costs																													0	0	0	4,641,807
proceeds from atm, net of offering costs
change in net unrealized loss on available-for-sale securities
change in net unrealized gain on available-for-sale securities																											28,740	30,872
maturity of short-term investment																												500,000
amortization of debt discount and deferred financing costs																																											220,152	38,140	0	1,110,013	138,267	25,267	464,498	50,883
unrealized loss on short-term equity securities
stock-based compensation expense to employees, directors and consultants																																							826,926
repayment of related-party notes payable																																	0	0	-563,842	-92,379	-128,140	-98,831
deferred offering costs in connection with future warrant repricing included in accounts payable and prepaid expenses and other current assets
amortization of debt discounts and deferred financing costs																																		0	0	6,130	6,266	6,197		65,435	65,435	286,133
prepaid expenses and other assets																														-379,524																																1,915	-43,652	-36,210	25,993	3,650	-121,864	40,727	59,465	29,001
proceeds from the public offering, net of offering costs
supplemental disclosure of non-cash investing activities:
unrealized loss on available-for-sale securities
reduction of accounts payable for returned fixed assets
offering costs included in additional paid-in capital and accounts payable and other accrued expenses																																				165,990
patent costs
proceeds from the april 2016 tender offer, net of offering costs
proceeds from the rights offering, net of offering costs																																					-186,652	1,185,368
proceeds from the october 2016 tender offer, net of offering costs
cumulative undeclared preferred dividends recorded upon conversion of class a convertible preferred stock and class b convertible preferred stock into common stock
estimated relative fair value of warrants issued in connection with related-party notes payable
leasehold improvements paid by tenant allowance included in accounts payable and accrued expenses
reclassification of shipper inventory to property and equipment
warrant repricing expense																																					0	1,929,818
trademark costs																																		-26,805	-14,529	-10,199
proceeds from the common stock offering, net of offering costs																																		0	-165,990	11,571,914
proceeds from april 2016 tender offer, net of offering costs
proceeds from exercise of stock options and warrants, net of costs
cumulative undeclared preferred dividends recorded upon conversion of class a convertible preferred stock and class b convertible preferred stock into common
reclassification of shipper inventory to fixed assets																																								0
leasehold improvements paid by tenant allowance included in accounts payable and other accrued expenses
issuance of common stock for accrued board of director compensation																																							0	0
estimated fair value of the beneficial conversion feature on related-party notes payable
other assets																																					-342,072	-16,022			-66,144	-25,192	55,196	-37,101	5,467	-13,388									18,214
acquisition of intangible
proceeds from the tender offer, net of offering costs																																					-46,200	2,290,447
proceeds from issuance of common stock and warrants in public offering, net of offering costs																																								0
proceeds from the issuance of class a and class b convertible preferred stock, net of offering costs
offering costs in connection with the rights offering included in accounts payable and other accrued expenses
purchase of fixed assets included in accounts payable and other accrued expenses
accretion of convertible preferred stock beneficial conversion feature and relative fair value of warrants issued in connection with the convertible preferred stock units to accumulated deficit																																							0	0	0	4,474,348	1,902,569	492,910	1,727,027	741,786
adjustments to reconcile net loss to net cash used in operating activities:
payment for deferred offering costs																																										-89,545
offering costs in connection with tender offer included in accounts payable and other accrued expenses																																						46,200
offering costs in connection with rights offering included in accounts payable and other accrued expenses																																						184,690
offering costs for future financing included in prepaid expenses and other current assets and accounts payable and other accrued expenses																																						24,204
deferred offering costs in connection with secondary public offering included in accounts payable and other accrued expenses
estimated relative fair value of beneficial conversion feature on related-party notes payable
loss on write-off of patents																																							0
proceeds from the issuance of notes payable
repayment of convertible debt
repayment of offering and deferred financing costs																																																		-67,475
estimated relative fair value of warrants issued in connection with notes payable																																											146,257
conversion of convertible debentures payable and accrued interest into convertible preferred stock units																																											0	0	0	1,766,997
estimated fair value of the beneficial conversion feature on related party notes payable
deposits and other current assets
proceeds from the issuance of preferred stock, net of offering costs																																								0	0	3,896,678		1,140,290	882,222	780,342
repayment of convertible debentures																																												0	0	-50,000
repayment of related party notes payable																																								-40,000	-60,000	-112,000		-24,000	-24,000	-24,000
offering costs in connection with convertible preferred stock included in accounts payable																																												0	0	9,658
fair value of common stock issued to consultant for future services included in other current assets
loss on disposal of cryogenic shippers																																											10,650	3,909	179	1,685	10,182	3,075			44,651	0							3,007	0	897	2,613	13,674
provision for (recovery of) bad debt																																										3,340
deferred offering costs in connection with secondary public offering included in accounts payable																																										51,153
change in fair value of derivative instruments																																															-3	-1,196	-892	-18,757	11,226	6,112	-14,489	-19,335	-10,010	-60,185	-14,685	-34,283	227,270	-33,987	-126,345	-116,528
debt conversion expense																																															0	552,750
deferred financing costs in connection with convertible debt payable included in accounts payable																																																	-42,491	70,234
estimated relative fair value of warrants issued in connection with convertible bridge notes payable
estimated relative fair value of warrants issued in connection with related-party convertible notes payable
conversion of bridge notes payable and accrued interest into common stock units
proceeds from issuance of notes payable
proceeds from issuance of convertible debentures
repayment of offering and deferred costs
estimated relative fair value of warrants issued in connection with convertible debentures payable
conversion of bridge notes payable and accrued interest into shares of common stock and warrants																																																150,027
net decrease in cash and cash equivalents																																													-67,162	-199,076
deferred financing costs in connection with convertible debentures payable included in accounts payable
recovery of bad debt																																														-5,349
loss on write-off of intangible assets
reserve for bad debt
purchases of intangible assets																																																							-207	-45,666	-54,210	-25,337	-28,571	-21,537				0
offering costs in connection with equity financing included in accounts payable																																																			0	-5,822
release of restricted cash for repayment of convertible debentures
cash flows from operating activities
fair value of stock options and warrants issued to employees, directors and consultants																																																178,746	174,017	157,203
other current assets																																																-13,271	1,140	-10,767		-18,400	-1,045	28,385			60,893	64,448
accounts payable and accrued expenses																																																350,935	-167,242	-54,278	142,143	223,125	47,406	30,894	-400,716	159,725	142,752	35,998	50,524
cash flows from investing activities
cash flows from financing activities
repayments of convertible debt
payments of offering and deferred financing costs																																																-115,880
repayments of related party notes payable																																																-24,000	-24,000	-24,000		-32,000	-24,000	-16,000		-24,000	-24,000	-30,000						-20,000	-30,000	-30,000	-30,000	-30,000	-30,000	-30,000
cash and cash equivalents, beginning of period																																																0	0	563,104		0	0	4,617,535		0	0	9,278,443						0	0	249,758		0	0	2,231,031
cash and cash equivalents, end of period																																																-312,499	304,939	227,530		-1,084,527	-1,301,933	2,971,567		-2,157,365	-2,103,150	7,056,604						-473,450	563,836	556,922		-442,880	-970,652	2,189,698
supplemental disclosure of cash flow information
cash paid during the period for:
interest																																																			0	0	3,099	12,577	0	24,547	38,413	50,345	22,727	1,741	12,967	2,133
income taxes																																																			0	0			0	0	0	1,600	0	0	0	1,600
release of restricted cash for repayment of convertible debentures payable																																																			0	0	0	251,368
estimated relative fair value of warrants issued in connection with convertible debt payable																																																	92,171	106,999
operating activities
fair value of warrants issued to convertible debenture holders
fair value of stock options and warrants issued to consultants, employees and directors																																																					168,190	80,836	31,110	157,441	198,949	171,591				152,067				272,312
interest accrued on restricted cash																																																							0	0	-126	-148	-145	-166	-228	-226					-477
investing activities
financing activities
proceeds from issuance of common stock, net of cash paid for issuance costs																																																											8,090,745
restricted cash – convertible debenture holder escrow account funds
proceeds from release of restricted cash																																																							0	0
payment on line of credit																																																							0	0
proceeds from exercise of options and warrants																																																															0	437,500			-1	0	0	3,308
cash and cash equivalents, beginning of year																																																													0	3,629,886
cash and cash equivalents, end of year																																																													1,648,543	2,097,202
cash paid during the year for:
cashless exercise of warrants and stock options
repayments of convertible debentures payable																																																				0	0	-82,800		-600,000	-600,000	-576,628
proceeds from exercise of warrants																																																								115,500	324,133	132,000
supplemental disclosure of non-cash activities:
cashless exercise of warrants
payment of financing costs																																																						-78,480														0
repayment of convertible debentures payable
repayment of deferred financing costs
proceeds from private placement of common stock, net of cash paid for issuance costs
restricted cash-investor funds
deposits from investors
amortization of deferred financing costs																																																															77,760	56,177	17,675	7,904	3,589	10,766	10,767	17,162
fair value of stock issued to consultants
share-based compensation related to stock options and warrants issued to consultants, employees and directors																																																											86,305	51,871
loss on sale of assets																																																															8,387	0	0	797
accrued warranty costs																																																															0	0			-5,625	0	0	-5,625
decrease in restricted cash																																																															-2,085
proceeds from borrowings under convertible notes																																																															0	0
repayments of note payable to officer																																																															-113,950	0			-12,000	-6,000	-18,000	-18,000
payment of fees associated with the exercise of warrants
payment of related party notes payable																																																												-30,000	-30,000	-30,000
payment of fees associated with exercise of warrants																																																																-25,458
stock issued to consultants																																																															0	47,287	12,000	106,807	80,332	63,100	77,170	28,500
accounts payable																																																													120,908	-205,513	179,451	-54,265	72,375	102,893	-113,531	83,131	12,974	1,561
net cash provided by financing activities
inventory
accrued compensation and related expense																																																														9,293
purchases of intangibles																																																														-44,381					0
accrued expenses																																																															-105,482	-97,436	112,278	93	-7,518	-338	-9,643	9,398
repayment of line of credit
fair value of warrants and options issued to employees and directors
fair value of warrants issued to consultants
change in fair value of derivative instrument																																																																-4,508,352	4,535,848	-3,134,298
interest earned on restricted cash																																																																0	-465	-597			-2,276	-2,250
accrued salaries and related																																																																-17,897	23,622	14,928	8,764	67,538	-3,871	-4,354
purchases of fixed assets																																																																-8,201	-1	-9,766	-300	-5,235	-23,544	-29,499
net cash (used in) provided by investing activities
repayment of convertible notes																																																																				0	0	-117,720
repayment of borrowings on line of credit																																																																				-3,000	-10,000	-12,500
fair value of warrants issued to employees and directors																																																																				-168,244
payment of trademark costs																																																																		-18,020			0	-633
net proceeds from borrowings under convertible notes																																																																		926,500		0	0	1,062,500
fair value of warrants issued to consultants, employees and directors
cash flows provided by (used in) investing activities:
net cash from (used in) investing activities
net proceeds from borrowings under line of credit
proceeds from issuance of common stock
decrease (increase) in restricted cash
fair value of stock options and warrants issued to employees and directors																																																																						53,887
investment in certificate of deposit
proceeds from borrowings under notes payable
cash flows used in investing activities:

Cryoport, Inc(NASDAQ:CYRX)

Cryoport, Inc
(NASDAQ:CYRX)